Health News
Analysis: Some Republicans see new scandal in Sebelius fundraising
WASHINGTON - With the White House already reeling from three major controversies, some Republican lawmakers are zeroing in on what they perceive is another possible scandal tied to President Barack Obama's landmark health reform law just as it nears implementation.
Pfizer halts study of lymphoma drug unlikely to help survival
- Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive non-Hodgkin lymphoma after independent monitors found it was not likely to improve survival.
Intercell vaccine gets U.S. pediatric approval
VIENNA - Austria's Intercell said on Tuesday it has won U.S. regulatory approval for pediatric use of its Ixiaro vaccine to protect against Japanese Encephalitis (JE), a step it had achieved in Europe in February.
Healthcare workers set to strike California public hospitals
SAN FRANCISCO - Nearly 13,000 healthcare employees at five University of California medical centers plan to strike on Tuesday in a move that threatens to back up emergency rooms and already has forced the postponement of elective surgeries.
AcelRX drug device meets main goal of late-stage study; shares jump
- AcelRX Pharmaceuticals Inc said its experimental drug device to treat post-operative pain met the main goal of controlling pain in a late-stage study among patients who had undergone knee or hip replacement surgery.
Bayer says lung drug shows promise in prolonged trial
FRANKFURT - Bayer said extended use of its experimental riociguat pill to treat a life-threatening form of high blood pressure in the lungs was shown to be safe and effective in a prolonged trial.
Regeneron, Sanofi asthma drug seen as potential game changer
- A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease, researchers said on Tuesday.
Health sites too complex, full of cliches: study
NEW YORK (Reuters Health) - The importance of health literacy hit home for Lisa Gualtieri when a Cambodian refugee diagnosed with cancer asked her to act as a patient advocate.
Pricey radiation no better post prostatectomy: study
NEW YORK (Reuters Health) - Men who get an older and less costly form of radiation after their cancerous prostates are removed fare just as well as men who get a new and expensive type of radiation, according to a new study.
Does prostate cancer treatment help older, sick men?
NEW YORK (Reuters Health) - Older men with other illnesses may not live long enough to benefit from aggressive prostate cancer treatments, such as prostate removal or radiation, and they'd have to live with their side effects, says a new study.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
